Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

.:: Intrasense [ALINS] ::.

Intrasense is a medical device company listed on Alternext Paris [ALINS], developping medical imaging software. The company’s lead product, Myrian, is a vendor-neutral software suite that can be used to analyze medical images acquired with any modality (MRI, CT Scan, X-Rays…).

From Nov 22th, 2017, Aurgalys analyst reports on Intrasense will be published in English and French

A partir du 22 novembre 2017, les rapports d’analyse d’Aurgalys sur Intrasense seront publiés en Français et en Anglais

The coverage was initiated Feb 15th, 2017

Our target price for Intrasense as of March 22th, 2018, is €1,2/ share

2018

2017